GIOVANNONI, SARA
GIOVANNONI, SARA
Antiangiogenic agents are ineffective to increase complete response rate in MRCC:A meta-analysis
2012 Iacovelli, Roberto; Altavilla, Amelia; Passaro, Antonio; Maria, Campennì Giuseppe; Alesini, Daniele; Palleschi, Michela; Modica, Daniela; Giovannoni, Sara; Manai, Chiara; Cortesi, Enrico
Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration
2014 Giovannoni, Sara; Trenta, Patrizia
BRAFV600E mutation positive metastatic melanoma in a young woman treated with anti-BRAF/anti MEK combination: a case report
2015 Giovannoni, Sara; Urbano, Federica; Modica, Daniela; Verkhovskaia, Sofia; Giuliana, Caprio; Mezi, Silvia; Cortesi, Enrico
Correlation between GCIG-CA125 and radiological progression in determining disease progression in patients receiving bevacizumab for advanced ovarian cancer: a retrospective study
2015 Giovannoni, Sara; Marchetti, Claudia; Maise, Al Bakir; Daniela, Luvero; Roberto, Angioli; Rebecca, Kristeleit; Mary, Mccormarck; BENEDETTI PANICI, Pierluigi; Jonathan, Ledermann
ENYGO Teach the Teachers & Complications in Gyneacological Oncology workshop
2014 Giovannoni, Sara; Michael, Halaska; Vladyslav, Suhin; Teunissen Pim, Salutari Vanda; Fanfani, Francesco
Erlotinib in metastatic non-small cell lung cancer (NSCLC) patients unselected for Epidermal Growth Factor Receptors (EGFR) mutations: a retrospective analysis of elderly patients
2012 Urbano, Federica; Trenta, Patrizia; Iacovelli, Roberto; Palazzo, Antonella; Giovannoni, Sara; LO RUSSO, Valentina; Mosillo, Claudia; Rubini, FILIPPO LORENZO; DE MARCHIS, Laura; Cortesi, Enrico
Etoricoxib and anastrozole in adjuvant early breast cancer: ETAN trial (phase III)
2011 M. S., Rosati; DI SERI, Marisa; Baciarello, Giacinto; V., Lo Russo; P., Grassi; L., Marchetti; Giovannoni, Sara; Basile, Maria Luisa; Frati, Luigi
Extending the platinum-free interval (PFI) with Trabectedin plus Pegylated liposomal doxorubicin (PLD) in a patient with partially platinum sensitive (PPS) recurrent ovarian cancer.
2015 Giovannoni, Sara; Marchetti, Claudia; Verkhovskaia, Sofia; Risi, Emanuela; DE BENEDETTO, Angelina; Cortesi, Enrico
Follow-up in patients with BRCA mutations; focus on ovarian cancer risk : a single-center experience
2014 Giovannoni, Sara; Maria, Campennì Giuseppe; Palleschi, Michela; Telesca, Marianna; Miglio, Elena; Cipolla, Valentina; DE FELICE, Carlo; Ballesio, Laura; Pediconi, Federica; Carmelilia, De Bernardo; Grammatico, Paola; Naso, Giuseppe; DE MARCHIS, Laura
Gemcitabine-induced extensive skin necrosis
2012 D'Epiro, Sara; Salvi, Monica; Mattozzi, Carlo; Giancristoforo, Simona; Campoli, Marco; Zanniello, Ramona; Luci, Cecilia; Macaluso, Laura; Giovannoni, Sara; Iacovelli, Roberto; Calvieri, Stefano; Richetta, Antonio Giovanni
Hereditary ovarian cancer
2017 Giovannoni, Sara
Il carcinoma del colon retto metastatico- Sicurezza ed efficiacia di Panitumumab dopo reazioni infusionali da Cetuximab nel carcinoma del colon retto metastatico
2012 Giovannoni, Sara; DE LUCA, Cristina; LO RUSSO, Valentina; Iolanda, Speranza; DI SERI, Marisa
Large cell neuroendocrine carcinoma (LCNEC) of the cervix in a BRCA2 VUS carrier woman responding to PARP inhibitor: a case report
2015 Giovannoni, Sara; Brown, N; Shaw, H; Kristeleit, R; Ledermann, Ja
Long-lasting complete response with trabectedin plu pegylated liposomal doxorubicin (PLD) in a young BRCA-mutated woman with platinum sensitive relapsed ovarian cancer (ROC) : a case report
2015 Giovannoni, Sara; Sofia, Verhovskaia; Marchetti, Claudia; Daniela, Luvero; Urbano, Federica; Mezi, Silvia; Cortesi, Enrico
Start-therapy in cancer pain management: news from the past
2009 Rosati, MARIA SOFIA; Raimondi, Cristina; Baciarello, Giulia; Grassi, Paolo; Giovannoni, Sara; Petrelli, Elena; DI SERI, Marisa
The role of systemic chemotherapy
2014 Trenta, Patrizia; Giovannoni, S.; Risi, E.; Cortesi, E.
The role of systemic chemotherapy
2015 Trenta, Patrizia; Giovannoni, Sara; Risi, Emanuela; Cortesi, Enrico
Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I-II)
2011 Rosati, MARIA SOFIA; Raimondi, Cristina; Baciarello, Giulia; Grassi, Paolo; Giovannoni, Sara; Petrelli, Elena; Basile, Maria Luisa; Girolami, Marco; DI SERI, Marisa; Frati, Luigi
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Antiangiogenic agents are ineffective to increase complete response rate in MRCC:A meta-analysis | 2012 | Iacovelli, Roberto; Altavilla, Amelia; Passaro, Antonio; Maria, Campennì Giuseppe; Alesini, Daniele; Palleschi, Michela; Modica, Daniela; Giovannoni, Sara; Manai, Chiara; Cortesi, Enrico | |
Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration | 2014 | Giovannoni, Sara; Trenta, Patrizia | |
BRAFV600E mutation positive metastatic melanoma in a young woman treated with anti-BRAF/anti MEK combination: a case report | 2015 | Giovannoni, Sara; Urbano, Federica; Modica, Daniela; Verkhovskaia, Sofia; Giuliana, Caprio; Mezi, Silvia; Cortesi, Enrico | |
Correlation between GCIG-CA125 and radiological progression in determining disease progression in patients receiving bevacizumab for advanced ovarian cancer: a retrospective study | 2015 | Giovannoni, Sara; Marchetti, Claudia; Maise, Al Bakir; Daniela, Luvero; Roberto, Angioli; Rebecca, Kristeleit; Mary, Mccormarck; BENEDETTI PANICI, Pierluigi; Jonathan, Ledermann | |
ENYGO Teach the Teachers & Complications in Gyneacological Oncology workshop | 2014 | Giovannoni, Sara; Michael, Halaska; Vladyslav, Suhin; Teunissen Pim, Salutari Vanda; Fanfani, Francesco | |
Erlotinib in metastatic non-small cell lung cancer (NSCLC) patients unselected for Epidermal Growth Factor Receptors (EGFR) mutations: a retrospective analysis of elderly patients | 2012 | Urbano, Federica; Trenta, Patrizia; Iacovelli, Roberto; Palazzo, Antonella; Giovannoni, Sara; LO RUSSO, Valentina; Mosillo, Claudia; Rubini, FILIPPO LORENZO; DE MARCHIS, Laura; Cortesi, Enrico | |
Etoricoxib and anastrozole in adjuvant early breast cancer: ETAN trial (phase III) | 2011 | M. S., Rosati; DI SERI, Marisa; Baciarello, Giacinto; V., Lo Russo; P., Grassi; L., Marchetti; Giovannoni, Sara; Basile, Maria Luisa; Frati, Luigi | |
Extending the platinum-free interval (PFI) with Trabectedin plus Pegylated liposomal doxorubicin (PLD) in a patient with partially platinum sensitive (PPS) recurrent ovarian cancer. | 2015 | Giovannoni, Sara; Marchetti, Claudia; Verkhovskaia, Sofia; Risi, Emanuela; DE BENEDETTO, Angelina; Cortesi, Enrico | |
Follow-up in patients with BRCA mutations; focus on ovarian cancer risk : a single-center experience | 2014 | Giovannoni, Sara; Maria, Campennì Giuseppe; Palleschi, Michela; Telesca, Marianna; Miglio, Elena; Cipolla, Valentina; DE FELICE, Carlo; Ballesio, Laura; Pediconi, Federica; Carmelilia, De Bernardo; Grammatico, Paola; Naso, Giuseppe; DE MARCHIS, Laura | |
Gemcitabine-induced extensive skin necrosis | 2012 | D'Epiro, Sara; Salvi, Monica; Mattozzi, Carlo; Giancristoforo, Simona; Campoli, Marco; Zanniello, Ramona; Luci, Cecilia; Macaluso, Laura; Giovannoni, Sara; Iacovelli, Roberto; Calvieri, Stefano; Richetta, Antonio Giovanni | |
Hereditary ovarian cancer | 2017 | Giovannoni, Sara | |
Il carcinoma del colon retto metastatico- Sicurezza ed efficiacia di Panitumumab dopo reazioni infusionali da Cetuximab nel carcinoma del colon retto metastatico | 2012 | Giovannoni, Sara; DE LUCA, Cristina; LO RUSSO, Valentina; Iolanda, Speranza; DI SERI, Marisa | |
Large cell neuroendocrine carcinoma (LCNEC) of the cervix in a BRCA2 VUS carrier woman responding to PARP inhibitor: a case report | 2015 | Giovannoni, Sara; Brown, N; Shaw, H; Kristeleit, R; Ledermann, Ja | |
Long-lasting complete response with trabectedin plu pegylated liposomal doxorubicin (PLD) in a young BRCA-mutated woman with platinum sensitive relapsed ovarian cancer (ROC) : a case report | 2015 | Giovannoni, Sara; Sofia, Verhovskaia; Marchetti, Claudia; Daniela, Luvero; Urbano, Federica; Mezi, Silvia; Cortesi, Enrico | |
Start-therapy in cancer pain management: news from the past | 2009 | Rosati, MARIA SOFIA; Raimondi, Cristina; Baciarello, Giulia; Grassi, Paolo; Giovannoni, Sara; Petrelli, Elena; DI SERI, Marisa | |
The role of systemic chemotherapy | 2014 | Trenta, Patrizia; Giovannoni, S.; Risi, E.; Cortesi, E. | |
The role of systemic chemotherapy | 2015 | Trenta, Patrizia; Giovannoni, Sara; Risi, Emanuela; Cortesi, Enrico | |
Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I-II) | 2011 | Rosati, MARIA SOFIA; Raimondi, Cristina; Baciarello, Giulia; Grassi, Paolo; Giovannoni, Sara; Petrelli, Elena; Basile, Maria Luisa; Girolami, Marco; DI SERI, Marisa; Frati, Luigi |